Ceracapsule (Cefaclor Hydrate)

Adult dose

Administer 250mg (equivalent) of cefaclor hydrate orally every 8 hours. For severe infections (such as pneumonia) and infections with low susceptibility, the dose can be doubled. In cases of acute gonococcal urethritis, this medication (3g) and probenecid (1g) can be administered together in a single dose.

Child dose

Administer 20mg (equivalent) per kg of body weight divided every 8 hours. For severe infections, otitis media, and infections with low susceptibility, a dose of 40mg (equivalent) per kg of body weight can be given, with a maximum dose of

This medication is an antibiotic that treats infections by destroying the cell walls of specific bacteria. Before using this medication, individuals with a history of allergic reactions or severe shock to this medication or similar antibiotics should not take it. Those with a penicillin allergy or individuals prone to allergic reactions such as asthma, rash, or hives should use this medication cautiously. Patients with severely impaired kidney function, elderly patients, or those who have difficulty swallowing should be closely monitored for the risk of bleeding due to vitamin K deficiency while taking this medication. Caution is necessary for patients with a history of gastrointestinal diseases, particularly colitis. During the treatment, rare but severe allergic reactions, skin rashes, blood abnormalities, liver or kidney dysfunction, gastrointestinal problems, respiratory issues, or central nervous system symptoms may occur; symptoms should be promptly reported to healthcare professionals. To prevent the development of resistant bacteria, it is recommended to confirm effectiveness against the infected bacteria and to use it only for the minimum necessary duration. When taken with other medications, interactions may occur, especially with drugs affecting the kidneys, anticoagulants, or oral contraceptives; consultation with a physician or pharmacist is essential. Pregnant or breastfeeding women should only take this medication if the benefits outweigh the risks, as its safety has not been fully established; caution is advised during breastfeeding. This medication should not be used in newborns less than 1 month old, as its safety and efficacy have not been established. Elderly patients may present adverse effects more easily due to decreased bodily functions, therefore, careful dosage adjustment and monitoring are required. This medication may affect the results of urine tests; thus, it is important to inform healthcare professionals about its use during testing.

Serious side effects

Shock, anaphylactic symptoms (swelling, difficulty breathing), hives, Stevens-Johnson syndrome, toxic epidermal necrolysis, jaundice, acute renal failure, severe colitis, interstitial pneumonia, eosinophilic lung infiltration, confusion, hallucinations, seizures, disorientation, visual disturbances, paralysis, severe edema

Mild side effects

Generalized flushing, vascular edema, sensory abnormalities, syncope, hypertension, vasodilation, rash, itching, fever, lymph node swelling, arthralgia, serum sickness-like reactions, blood system abnormalities (agranulocytosis, granulocytopenia, pancytopenia, anemia, thrombocytopenia, eosinophilia, lymphocytosis, leukopenia, aplastic anemia, hemolytic anemia, reversible neutropenia), transient hepatitis, increased AST, ALT, ALP, nausea, vomiting,

This medication should be stored in a tightly sealed container that blocks light, at room temperature between 1 and 30 degrees Celsius. Storing it this way will safely maintain the drug's effectiveness.

Appearance

Capsule with a purple upper part and a white lower part containing a pale yellow powder

Package unit

30 capsules/bottle, 300 capsules/bottle